NFKB1 and chronic obstructive pulmonary disease: NF-κB is activated in lung epithelial cells and macrophages of COPD patients and regulates the increased expression of proinflammatory cytokines, such as tumour necrosis factor(TNF)-α, interleukin(IL)-1β and IL-6, all of which are increased in COPD patients.